GlassScriptPhysician profile
Francesca Hoehne
NPI 1093725442
$1,261.34
in general payments reported to CMS, 2019-2025
30 companies · $101 in 2025
The $101 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $222 · 2021: $269 · 2022: $153 · 2023: $108 · 2024: $117 · 2025: $101.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $326.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $326.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $207.55 | 2019-2022 | |
| Eisai INC. | $114.31 | 2020-2023 | |
| Medtronic, INC. | $79.17 | 2024-2025 | Osteocool Rf Ablation System, Kyphon Express II Kyphopak Tray |
| Daiichi Sankyo INC. | $72.28 | 2020-2023 | Injectafer |
| E.R. Squibb & Sons, L.L.C. | $66.39 | 2021-2024 | Opdivo |
| Astrazeneca Pharmaceuticals LP | $58.90 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $54.78 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $53.22 | 2019-2021 | |
| Genentech USA, INC. | $47.12 | 2024 | Phesgo |
| Bayer Healthcare Pharmaceuticals INC. | $44.03 | 2020 | |
| Ethicon US, LLC | $43.66 | 2025 | Vistaseal, Harmonic |
| Incyte Corporation | $41.99 | 2019 | |
| Merck Sharp & Dohme LLC | $40.99 | 2021-2025 | Keytruda, Keytruda Qlex |
| Genzyme Corporation | $34.12 | 2020-2022 | |
| Regeneron Healthcare Solutions, INC. | $25.37 | 2019 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $25.24 | 2019-2020 | |
| Myriad Genetic Laboratories, INC. | $23.02 | 2022 | |
| Hologic Sales and Service, LLC | $22.93 | 2022 | |
| Myovant Sciences INC. | $22.77 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.65 | 2019 | |
| Jazz Pharmaceuticals INC. | $20.22 | 2020 | |
| Janssen Biotech, INC. | $18.96 | 2022 | |
| Abbvie INC. | $18.13 | 2019 | |
| Seagen INC. | $17.89 | 2021 | |
| Taiho Oncology, INC. | $17.22 | 2023 | |
| Gilead Sciences, INC. | $15.99 | 2023 | |
| Smith+Nephew, INC. | $15.11 | 2023 | Pico |
| Mirati Therapeutics, INC. | $14.27 | 2023 | Krazati |
| Puma Biotechnology, INC. | $14.23 | 2021 | |
| Exelixis INC. | $10.83 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Francesca Hoehne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.